Your browser doesn't support javascript.
loading
Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
Yousef, Abdelrahman; Yousef, Mahmoud; Chowdhury, Saikat; Abdilleh, Kawther; Knafl, Mark; Edelkamp, Paul; Alfaro-Munoz, Kristin; Chacko, Ray; Peterson, Jennifer; Smaglo, Brandon G; Wolff, Robert A; Pant, Shubham; Lee, Michael S; Willis, Jason; Overman, Michael; Doss, Sudheer; Matrisian, Lynn; Hurd, Mark W; Snyder, Rebecca; Katz, Matthew H G; Wang, Huamin; Maitra, Anirban; Shen, John Paul; Zhao, Dan.
Affiliation
  • Yousef A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yousef M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Abdilleh K; Pancreatic Cancer Action Network, Manhattan Beach, Los Angeles, CA, USA.
  • Knafl M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Edelkamp P; Department of Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alfaro-Munoz K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chacko R; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Peterson J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Smaglo BG; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee MS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Willis J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Overman M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Doss S; Pancreatic Cancer Action Network, Manhattan Beach, Los Angeles, CA, USA.
  • Matrisian L; Pancreatic Cancer Action Network, Manhattan Beach, Los Angeles, CA, USA.
  • Hurd MW; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Snyder R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maitra A; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shen JP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhao D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Res Sq ; 2023 Aug 10.
Article in En | MEDLINE | ID: mdl-37609177
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Res Sq Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies Language: En Journal: Res Sq Year: 2023 Document type: Article